IRIDEX (IRIX)
(Delayed Data from NSDQ)
$1.39 USD
+0.03 (2.21%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $1.37 -0.02 (-1.44%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
IRIX 1.39 +0.03(2.21%)
Will IRIX be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for IRIX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRIX
RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings?
Rockwell Medical on Expansion Spree: Should You Buy the Stock Now?
IRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
Other News for IRIX
IRIDEX (IRIX) Stock Dives Over 5% Amid Financial Struggles
IRIX Stock Sees Significant Drop Amid Market Fluctuation
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
Iridex Announces New CEO and Strategic Leadership Changes